Peer-reviewed veterinary case report
Yeast treatment tested for chronic gut disease in dogs
By D'Angelo, Simona et al.·Published in The Veterinary record·2018·Department of Veterinary Medical Sciences, Italy·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Effect ofin dog with chronic enteropathies: double-blinded, placebo-controlled study.
- Species:
- dog
Plain-English summary
A group of dogs with chronic digestive issues, known as chronic enteropathies, were treated with a specific yeast supplement alongside their regular medications. Over 60 days, those receiving the yeast showed significant improvements in their symptoms, including better stool consistency and less frequent bathroom trips, compared to those who only received a placebo. The treatment was safe, with no noticeable side effects reported. This suggests that the yeast could be a helpful addition to the treatment plan for dogs suffering from chronic digestive problems.
People also search for: dog chronic diarrhea treatment · yeast for dog digestive issues · improving dog stool consistency
Abstract
is used to treat acute and chronic enteropathies in humans, but to date, no studies have evaluated the use of this yeast in dogs. The current study, a prospective non-randomised, double-blinded, placebo-controlled study, evaluated the effects ofin healthy dogs and dogs with chronic enteropathies (CE). Four healthy dogs and 20 dogs with CE were included. In healthy dogs,was administered for 10 days. Possible short-term adverse effects were recorded, and quantitative stool cultures for yeasts were performed. In dogs with CE,or a placebo was administered in addition to standard treatment protocols. Canine Chronic Enteropathy Clinical Activity Index, abdominal ultrasonography, gastroenteroscopy and histology were performed at the time of diagnosis and after 60 days of treatment. In healthy dogs,reached a steady state in five days and was completely eliminated on day 4 after administration. No short-term side effects were seen. Clinical activity index, stool frequency, stool consistency and body condition score improved significantly in dogs with CE receivingversus the placebo. In conclusion,can be safely used in dogs with CE and seems to achieve better control of clinical signs than standard therapy alone.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/29212912/